ArticleBrain : a journal of neurology2021

Engineered microRNA-based regulatory element permits safe high-dose miniMECP2 gene therapy in Rett mice.

Sarah E Sinnett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.